Singapore's National Precision Medicine (NPM) Programme Engages Oxford Nanopore To Advance Understanding Of The Genetics Of Singapore's Multi-Ethnic Population

OXFORD, England, Aug 5 (Bernama) -- Oxford Nanopore Technologies (Oxford Nanopore) has announced a landmark project with Singapore's National Precision Medicine (NPM) programme, led by Precision Health Research, Singapore (PRECISE), aimed at developing a comprehensive structural variant catalogue representing three major ethnic groups in Singapore including Chinese, Malay and Indian ethnicities. These genetic variations have demonstrated significance in helping clinician scientists and researchers in understanding human genetic diversity and diseases. This initiative underscores Oxford Nanopore’s commitment to advancing genetic research and healthcare outcomes on a global scale, particularly for ethnically diverse populations that are typically underrepresented in genomic databases.

Oxford Nanopore’s portion of the project will focus on sequencing 10,000 genomes representing Singapore’s diverse population, including Malay, Indian, and Chinese communities participating in the PRECISE-SG100K population cohort. This project will use Oxford Nanopore’s fleet of high-output PromethION 48 sequencing devices to deliver detailed, comprehensive genomic data to advance research and support precision healthcare. The project started mid-2024 and will run up to 12 months.